Disney websites are abuzz today with the new “testing of the RFID turnstiles” at Epcot. Read all about it at TouringPlans.com here, WDWMAGIC here, ThemeParkReview.com here, etc. Your choice. I went to Downtown Disney for Festival of the Masters instead of Epcot this morning, so I haven’t experienced this iteration of the “test” personally.
I just want to point out a couple of things. First of all, this is so far away from the “NextGen” end game, that it’s almost irrelevant. The purpose of “RFID” isn’t necessarily to streamline the admission process. It’s just the first of many steps toward the billion dollar “NextGen Project,” whatever that turns out to be. Most of what’s “known” about NextGen and Disney’s use of RFID is based on this article, which is entirely erroneous (and a carefully planted “leak”). The major slowdown with admission to the Parks is the “finger scan,” not the physical act of moving past the turnstile. If I had a nickel for every time I heard a Cast Member ask, “Is this the same finger you used last time?” I wouldn’t have to plaster this website with advertising to make a living. Second, if stickers and wristbands are “the future,” I want a refund. It’s not that cool. It’s not even particularly neat. You scan your ticket, which has a sticker embedded with a radio-frequency identification chip, put your finger on the same scanner that you’ve always used, and then enter the Park. Which is cool in what way? This is the same country that went to the moon, right? Citizens of the country, I mean. The same country that developed a vaccine for prostate cancer that reads like this:
A course of Sipuleucel-T treatment consists of three basic steps:
- A patient’s own white blood cells, primarily antigen-presenting cells (APCs), also called Dendritic cells, are extracted in a leukapheresis procedure.
- The blood product is sent to the factory and incubated with a fusion protein (PA2024) consisting of two parts,
- The activated blood product (APC8015) is returned from the factory to the infusion center and re-infused into the patient to cause an immune response against cancer cells carrying the PAP antigen.
A complete Sipuleucel-T treatment repeats three courses over the span of a month, with two weeks between successive courses.
And we’re excited about stickers? Tell me you’re kidding.